Details for New Drug Application (NDA): 214024
NDA 214024 describes TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE, which is a drug marketed by MSN and Natco and is included in two NDAs. Additional details are available on the TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE profile page.
The generic ingredient in TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE is tipiracil hydrochloride; trifluridine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the tipiracil hydrochloride; trifluridine profile page.
The generic ingredient in TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE is tipiracil hydrochloride; trifluridine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the tipiracil hydrochloride; trifluridine profile page.
Summary for 214024
| Tradename: | TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE |
| Applicant: | Msn |
| Ingredient: | tipiracil hydrochloride; trifluridine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 6.14MG BASE;15MG | ||||
| Approval Date: | Jan 8, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 8.19MG BASE;20MG | ||||
| Approval Date: | Jan 8, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
